Course Overview
Closing the Treatment Gap in Allergic Rhinitis: The Risks of Asthma and Other Comorbidities
Overview: AR is the sixth most prevalent chronic illness in the United States, affecting up to 30% of adults and 40% of children. Poorly controlled AR, either through patient self-medication or physician undertreatment, can add to the morbidity and economic burden of allergic disease. In this certified CME series, follow the diagnosis and treatment of four unique allergic rhinitis (AR) patients, whose stories are presented through brief, Web-based activities, or Webisodes.
Faculty
Michael S. Blaiss, MD
Clinical Professor of Pediatrics and Medicine
Division of Immunology and Allergy
University of Tennessee Health Science Center
Memphis, TN
Credits available: A maximum of 0.5 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
Expires: 6/3/10
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by
an educational grant from:
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
